The Efficacy and Safety of Tolvaptan Treatment in Patients with Congestive Heart Failure

被引：0
|
作者：
Seo, Yoshihiro [1 ]
Ishizu, Tomoko [1 ]
Sakai, Satoshi [1 ]
Kawano, Satoru [1 ]
Aonuma, Kazutaka [1 ]
机构：
[1] Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Cardiovasc, Tsukuba, Ibaraki, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2011年 / 17卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF IBOPAMINE IN CONGESTIVE-HEART-FAILURE
    VANVELDHUISEN, DJ
    GIRBES, ARJ
    CRIJNS, HJ
    SMIT, AJ
    DEGRAEFF, PA
    LIE, KI
    JOURNAL OF AUTONOMIC PHARMACOLOGY, 1990, 10 : S115 - S121
  • [32] Safety and efficacy of carvedilol in children with congestive heart failure
    Rusconi, P
    Marin, JR
    Redha, E
    Rossique-Gonzalez, M
    Young, ML
    Wolff, GS
    PEDIATRIC RESEARCH, 2000, 47 (04) : 49A - 49A
  • [33] COMPARISON OF THE SAFETY AND EFFICACY OF DELAPRIL WITH ENALAPRIL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    RENGO, F
    ACANFORA, D
    FURGI, G
    PAPA, A
    NICOLINO, A
    PICONE, C
    VITALE, DF
    RENGO, C
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (16): : F25 - F28
  • [34] Hyponatraemia and congestive heart failure refractory to diuretic treatment. Utility of tolvaptan
    Pose, A.
    Almenar, L.
    Manzano, L.
    Gavira, J. J.
    Lopez Granados, A.
    Delgado, J.
    Aramburu, O.
    Arevalo, J. C.
    Mendez, M.
    Comin, J.
    Manito, N.
    REVISTA CLINICA ESPANOLA, 2017, 217 (07): : 398 - 404
  • [35] Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience
    Park, Gun Ha
    Lee, Chang Min
    Song, Jae Won
    Jung, Moon Chan
    Kim, Jwa Kyung
    Song, Young Rim
    Kim, Hyung Jik
    Kim, Sung Gyun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2018, 33 (03): : 561 - 567
  • [36] Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis
    Wu, Mei-Yi
    Chen, Tzu-Ting
    Chen, Ying-Chun
    Tarng, Der-Cherng
    Wu, Yun-Chun
    Lin, Hsien-Ho
    Tu, Yu-Kang
    PLOS ONE, 2017, 12 (09):
  • [37] Pharmacokinetics, pharmacodynamics and efficacy of OPC-61815, prodrug of tolvaptan for intravenous administration, in patients with congestive heart failure
    Sato, N.
    Uno, S.
    Yamasaki, Y.
    Watanabe, S.
    Hirano, T.
    EUROPEAN HEART JOURNAL, 2020, 41 : 103 - 103
  • [38] Efficacy and safety of tolvaptan in acute heart failure patients during long-distance transportation
    Iwata, Shuko
    Yamaki, Masaru
    Nishiura, Takeshi
    Nakagawa, Keita
    Tokuno, Shota
    Sakai, Hirotsuka
    Okada, Motoi
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 51 : 58 - 63
  • [39] The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure
    Lin, Yen-Hung
    Tsai, Cheng-Hsuan
    Chiang, Chern-En
    Kuo, Jen-Yuan
    Yin, Wei-Hsian
    Wen, Ming-Shien
    Lo, Ping-Han
    Liu, Ping-Yen
    Lin, Tsung-Hsien
    Chen, Zhih-Cherng
    Shyu, Kou-Gi
    Hung, Ming-Jui
    Hwang, Juey-Jen
    Tseng, Chuen-Den
    ACTA CARDIOLOGICA SINICA, 2022, 38 (06) : 700 - 713
  • [40] Safety and Efficacy of Tolvaptan in the Elderly Patients with Acute Decompensated Heart Failure Requiring Repetitive Hospitalization
    Seki, Toshimasa
    Yazaki, Yoshikazu
    Horigome, Mitsuaki
    Ikeda, Uichi
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S151 - S152
12345